Story Poster
Photo by Auburn Athletics
Basketball Recruiting

Who's in the mix for Justin Powell?

March 11, 2021

“Describe the transfer portal in one word?”


I could describe the transfer portal in many ways but the most appropriate term I could’ve come up with is active. I feel like the portal is just always active and someone is either entering it or just speaking on it. It saw a major hit on Wednesday when Justin Powell, a star frosh at Auburn, became one of nearly 300+ names in the transfer portal.

Powell appeared in 10 games for the Tigers, averaging 11.7 points, 6.1 boards, and 4.7 assists. He has rated anywhere from a three-star to a four-star but exceeded the expectations of the Tiger faithful and those who just base a guy off an interesting ranking.

He didn’t exceed my expectations. Entering the season, I listed Powell as a notable freshman to watch in the SEC, now, I currently have him on my 2022 NBA Draft board.

Before that though, Powell will need to find his next spot, but, regardless of where he goes, I believe he’s going to pick up where he left off. The reason we didn’t see more of him this season is due to a major concussion that he suffered earlier in the year. He worked his butt off in efforts to make a possible late-season return.

Powell is definitely getting better and will be ready to work when he arrives at his next spot. So, what are some potential spots?

The following programs reached out to Powell, as we reported yesterday:

“UCLA, Gonzaga, Baylor, Georgia Tech, Kentucky, Louisville, Memphis, Virginia, Dayton, Oklahoma, Oklahoma State, Nebraska, Georgetown, UConn, Oregon, Texas A&M, Arkansas, Wake Forest, NC State, and Western Kentucky.”

There have been reported rumors of a favorite (Kentucky), those of which are all FALSE and incorrect. Powell will hear out each and every school, no leader is true. He will likely go through the zoom call process and speak to each coaching staff here soon.


subscribe Verify your student status
See Subscription Benefits
Trial only available to users who have never subscribed or participated in a previous trial.